Ignite Creation Date:
2024-05-05 @ 4:57 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00356889
Status:
COMPLETED
Last Update Posted:
2014-05-28
First Post:
2006-07-26
Brief Title:
Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic or Unresectable Biliary Tumors
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Unresectable Gallbladder Cancer |
| Cholangiocarcinoma of the Extrahepatic Bile Duct |
| Cholangiocarcinoma of the Gallbladder |
| Gastrointestinal Cancer |
| Recurrent Extrahepatic Bile Duct Cancer |
| Recurrent Gallbladder Cancer |
| Unresectable Extrahepatic Bile Duct Cancer |
Keywords: